Skip to main content

Advertisement

SpringerLink
Log in

Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Dang TP . Notch, apoptosis and cancer. Adv Exp Med Biol 2012; 727: 199–209.

    Article  CAS  Google Scholar 

  2. Watt FM, Estrach S, Ambler CA . Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 2008; 20: 171–179.

    Article  CAS  PubMed Central  Google Scholar 

  3. Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D et al. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta 2010; 1806: 258–267.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Kopan R, Ilagan MX . The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216–233.

    Article  CAS  PubMed Central  Google Scholar 

  5. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649–661.

    Article  CAS  PubMed Central  Google Scholar 

  6. Weng AP, Ferrando AA, Lee W, JPt Morris, Silverman LB . Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271.

    Article  CAS  Google Scholar 

  7. Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204: 1825–1835.

    Article  CAS  PubMed Central  Google Scholar 

  8. Koch U, Radtke F . Notch in T-ALL: new players in a complex disease. Trends Immunol 2011; 32: 434–442.

    Article  CAS  Google Scholar 

  9. Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009; 459: 1000–1004.

    Article  CAS  PubMed Central  Google Scholar 

  10. Real PJ, Ferrando AA . NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia 2009; 23: 1374–1377.

    Article  CAS  PubMed Central  Google Scholar 

  11. Inaba H, Pui CH . Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010; 11: 1096–1106.

    Article  CAS  PubMed Central  Google Scholar 

  12. Tissing WJ, Meijerink JP, den Boer ML, Pieters R . Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003; 17: 17–25.

    Article  CAS  Google Scholar 

  13. Tsai SY, Carlstedt-Duke J, Weigel NL, Dahlman K, Gustafsson JA, Tsai MJ et al. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 1988; 55: 361–369.

    Article  CAS  Google Scholar 

  14. Ray A, Prefontaine KE . Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752–756.

    Article  CAS  Google Scholar 

  15. Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 2009; 15: 50–58.

    Article  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr Cathrin Brisken, École Polytechnique Fédérale De Lausanne, for kindly providing the Notch1-IC retroviral construct. This work was supported by NotchIT ITN Project; FP7-MC-ITN 215761.

Author information

Author notes

  1. S Cialfi and R Palermo: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy

    S Cialfi, R Palermo, S Manca, S Checquolo, D Bellavia, M Pelullo, R Quaranta, A Gulino, I Screpanti & C Talora

  2. Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University of Rome, Rome, Italy

    S Cialfi & C Dominici

Authors
  1. S Cialfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Palermo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Manca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Checquolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Bellavia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Pelullo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Quaranta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C Dominici
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Gulino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. I Screpanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C Talora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to I Screpanti or C Talora.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cialfi, S., Palermo, R., Manca, S. et al. Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression. Leukemia 27, 485–488 (2013). https://doi.org/10.1038/leu.2012.192

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.192

  • Springer Nature Limited

This article is cited by

Search

Navigation